Fourth quarter revenue was $4.0 million, up 2% sequentially
387 patients added to the pipeline in fourth quarter, up 75% compared with Q4 2021
Conference call begins at 10:00 a.m. Eastern time today
BOSTON (March 13, 2023) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced financial results for the three months and full year ended December, 31, 2022. Read more.